Related Experiment Videos
Quantitation of basic fibroblast growth factor by immunoassay using BIAcore 2000
1Pharmaceutics Department, Scios Inc., Sunnyvale, CA 94086, USA.
Journal of Pharmaceutical and Biomedical Analysis
|December 29, 2000
Summary
A new immunoassay accurately quantifies basic fibroblast growth factor (bFGF) using a BIAcore biosensor. This sensitive method is reliable for bFGF detection in research and development studies.
Area of Science:
- Biochemistry
- Immunology
- Biosensor Technology
Background:
- Basic fibroblast growth factor (bFGF) is crucial in cellular processes.
- Accurate quantification of bFGF is essential for research and development.
- Existing methods for bFGF detection may lack sensitivity or efficiency.
Purpose of the Study:
- To develop and validate a sensitive, accurate, and efficient immunoassay for bFGF quantitation.
- To utilize a BIAcore 2000 biosensor instrument for bFGF detection.
- To establish a reliable method for bFGF analysis in various matrices.
Main Methods:
- Immobilization of anti-bFGF monoclonal antibody 48.1 (MAb 48.1) onto a Sensor Chip CM5 via amine coupling.
- Utilizing the immobilized MAb 48.1 sensor surface for bFGF detection and quantitation.
- Validation of the assay's sensitivity, accuracy, precision, and stability.
Main Results:
- The immunoassay demonstrated a reliable detection range of 5.65 to 1440 ng/ml bFGF.
- High immobilization level and reproducibility of MAb 48.1 were achieved.
- The assay showed excellent intra- and interassay precision (CVs < 8.5%) and stability over 150 regeneration cycles.
- No interference was observed from common biological and pharmaceutical matrices.
Conclusions:
- A validated, sensitive, and accurate immunoassay for bFGF quantitation using BIAcore technology has been developed.
- The assay exhibits high precision, accuracy, and specificity, making it suitable for research and development.
- The method's robustness and stability ensure its utility in diverse experimental settings.